NAYA Biosciences, Inc.
NAYA · NASDAQ
3/31/2025 | 12/31/2024 | 9/30/2024 | 6/30/2024 | |
|---|---|---|---|---|
| Market Cap | $1 | $3 | $3 | $36 |
| - Cash | $1 | $1 | $0 | $1 |
| + Debt | $9 | $10 | $5 | $5 |
| Enterprise Value | $9 | $12 | $8 | $41 |
| Revenue | $2 | $2 | $1 | $2 |
| % Growth | -2.9% | 17.6% | -22% | – |
| Gross Profit | $1 | $1 | $0 | $1 |
| % Margin | 36.2% | 43.2% | 31% | 53.1% |
| EBITDA | -$17 | -$3 | -$1 | -$2 |
| % Margin | -1,029.7% | -190.6% | -76.6% | -89.6% |
| Net Income | -$17 | -$4 | -$2 | -$2 |
| % Margin | -1,063% | -214.9% | -113.8% | -122.2% |
| EPS Diluted | -56.22 | -9.04 | -5.04 | -0.622 |
| % Growth | -521.9% | -79.4% | -710.3% | – |
| Operating Cash Flow | -$4 | -$1 | -$1 | -$1 |
| Capital Expenditures | -$0 | -$0 | $0 | -$0 |
| Free Cash Flow | -$4 | -$1 | -$1 | -$2 |